Orthofix Medical Inc. (OFIX) Fair Value 2026

OFIX · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 5 models active

Value Trap Risk

WARN (46/100)

Quick Summary — As of 2026-08-27, Orthofix Medical Inc. (OFIX) trades at $9.63, versus a $10.85 median fair value across its 5 active models — 12.7% above the current price. QOC: 6.2/10. Value Trap Risk: 46/100 (WARN). 5/13 models active.

Key Facts

Ticker
OFIX
Price
$9.63
Quality Score
6.2/10
Value Trap Risk
46/100
Models Active
5/13
Last Updated
Strength: CUCE Ensemble suggests +12.7% upside with 7% confidence
Risk: Value Trap score of 46 suggests caution despite apparent undervaluation

Is Orthofix Medical Inc. (OFIX) Undervalued or Overvalued in 2026?

According to CirclFi’s 5-model valuation engine, Orthofix Medical Inc. (OFIX) appears undervalued as of : the median of 5 independent fair value estimates is $10.85, 12.7% above the current price of $9.63. Estimates range from $5.08 to $26.17. OFIX scores 6.2/10 on fundamental quality and 46/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. OFIX’s +12.7% gap is narrower than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Orthofix Medical Inc. Stock in 2026? →

What Fair Value Does Each Model Give OFIX?

5 Intrinsic Value Models vs. Current Price ($9.63)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $10.85 +12.7%
Asset-Based · High Conviction
 $5.08 -47.2%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is OFIX's Fair Value Range?

Spread across 5 independent models · $5.08 to $26.17

CirclFi's 5 active models place Orthofix Medical Inc. (OFIX) between $5.08 and $26.17 per share, a spread of 194% of the median. The median of that range — $10.85 — is the fair value CirclFi publishes for OFIX, against a current price of $9.63.

Low · Dynamic NAVHigh · FTNN
$5.08median $10.85$26.17
Where the range comes from
Most bearish modelDynamic NAV$5.08
Most bullish modelFTNN Topology$26.17
Model agreement3 bullish · 2 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for OFIX. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on OFIX, not a CirclFi price target. How each model works →

What Is Orthofix Medical Inc. (OFIX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Orthofix Medical Inc.'s intrinsic value is estimated at a median fair value of $10.85. While the stock appears modestly undervalued at $9.63 (implied upside of +12.7%), our analysis suggests a thinner margin of safety across 3 of 5 bullish models. Notably, FTNN sees the most upside at +171.7% (fair value: $26.17), while Dynamic NAV is the most conservative at -47.2% ($5.08). The spread between these extremes — +218.9% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About OFIX?

5 of 13 models are currently active for OFIX. Of these, 3 models suggest upside while 2 models suggest overvaluation. Taken together, their median fair value for OFIX is $10.85 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does OFIX Rank in Medical Devices?

Among 157 Medical Devices stocks, OFIX ranks #79 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to healthcare company businesses. For Orthofix Medical Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.

Is OFIX a Value Trap?

CirclFi's Value Trap algorithm assigns OFIX a score of 46/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for Orthofix Medical Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Orthofix Medical Inc. scores 6.2 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +218.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every OFIX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across OFIX's 5 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Orthofix Medical Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

AHCOAdaptHealth Corp.QOC 6.3STIMNeuronetics, Inc.QOC 6.2PETVPetVivo Holdings, Inc.QOC 6.3NSPRInspireMD, Inc.QOC 6.1APYXApyx Medical CorporationQOC 6.3OMOutset Medical, Inc.QOC 6.1CTSOCytosorbents CorporationQOC 5.2ITOCiTonic Holdings Ltd.QOC 2.5SGHTSight Sciences, Inc.QOC 7.3IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: AHCO · STIM · PETV · NSPR · APYX · OM · CTSO · ITOC · SGHT · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to OFIX?

7 companies across all industries closest to OFIX’s Quality of Company score of 6.2/10.

TTSHTile Shop Holdings, Inc.QOC 6.2SASeabridge Gold Inc.QOC 6.2NWENorthWestern Energy Group, Inc.QOC 6.2NTIPNetwork-1 Technologies, Inc.QOC 6.2QUIKQuickLogic CorporationQOC 6.2LGIHLGI Homes, Inc.QOC 6.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: TTSH · SA · NWE · NTIP · QUIK · LGIH · NVDA

Where Does OFIX Sit in CirclFi's Medical Devices Rankings?

OFIX is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Orthofix Medical Inc.’s Valuation?

What is Orthofix Medical Inc.'s intrinsic value in 2026?

CirclFi puts Orthofix Medical Inc. (OFIX)'s intrinsic value at $10.85 — the median of 5 independent model estimates as of 2026-08-27, ranging from $5.08 to $26.17. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is OFIX overvalued or undervalued right now?

At $9.63, 3 of 5 active models suggest OFIX may be undervalued, while 2 indicate potential overvaluation. The median of all 5 fair value estimates is $10.85, 12.7% above the current price of $9.63 — a consensus view that OFIX is undervalued. The assessment depends on which methodology best fits Orthofix Medical Inc.'s business model in Medical Devices.

What does a Quality of Company score of 6.2 mean for OFIX?

Orthofix Medical Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on OFIX?

CirclFi analyzes OFIX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on OFIX?

Of the 5 models currently active on OFIX, FTNN Topology is the most bullish at $26.17 per share, and Dynamic NAV is the most bearish at $5.08. CirclFi's published fair value for OFIX is the median of that range, $10.85, not either extreme. The gap between the two ends equals 194% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is OFIX a value trap in 2026?

Orthofix Medical Inc.'s Value Trap score is 46/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries.

Cite this analysis — “According to CirclFi’s 5-model valuation engine, Orthofix Medical Inc. (OFIX) has a median fair value of $10.85 — 12.7% above the current price of $9.63 — as of 2026-08-27.” Source: circlfi.com/stock/OFIX/ · Methodology
Primary sources for this OFIX valuation
  • Financial statements: Orthofix Medical Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000884624) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for OFIX as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on OFIX.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for OFIX Unlock All 5 — $39/mo